VERI-5®
VERI-5® uses machine-learning-supported analysis to confirm bacterial infection in minutes by identifying bacteria directly from samples.
- ✓Pathogen identification in 15 minutes
- ✓Direct-from-sample workflow
- ✓Designed for point-of-care use
FluoretiQ is developing rapid point-of-care diagnostics for urinary tract infections, connecting bacterial identification with antibiotic sensitivity insight to support the right prescription sooner.
FluoretiQ’s human health roadmap combines VERI-5® pathogen identification with SCFI™ antibiotic sensitivity testing, supporting clinicians with actionable information closer to the patient consultation.
VERI-5® uses machine-learning-supported analysis to confirm bacterial infection in minutes by identifying bacteria directly from samples.
SCFI™ is being developed to determine antibiotic sensitivity rapidly, helping support evidence-based treatment decisions for UTI pathways.